More tools:Markets·Screener·Research·Chat

BioLife Solutions Inc. (BLFS) Financial Statements

BioLife Solutions Inc.
SIC 3845 · ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
FIGI BBG001SFGWZ7
XNAS · usd
35.38▲ 0.13 (0.37%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close35.25
Day's Range35.03 – 36.06
52-Week Range17.85 – 38.10
Volume788.0K
Avg Volume766.6K
Share Statistics
Shares Outstanding
Employees155
ExchangeXNAS
Listed1989-11-22
Share count as of July 30, 2026
Loading Income Statement…
Key questions about BioLife Solutions Inc. (BLFS)
What is BioLife Solutions Inc.'s Market Cap?
BioLife Solutions Inc.'s Market Cap is $1.7B, based on as-reported figures from SEC (XBRL) filings.
What is BioLife Solutions Inc.'s Enterprise Value?
BioLife Solutions Inc.'s Enterprise Value is $1.7B, based on as-reported figures from SEC (XBRL) filings.
What is BioLife Solutions Inc.'s Trailing P/E?
BioLife Solutions Inc.'s Trailing P/E is 29.8×, based on as-reported figures from SEC (XBRL) filings.
What is BioLife Solutions Inc.'s Price / Sales?
BioLife Solutions Inc.'s Price / Sales is 16.2×, based on as-reported figures from SEC (XBRL) filings.
What is BioLife Solutions Inc.'s EV / Revenue?
BioLife Solutions Inc.'s EV / Revenue is 16.0×, based on as-reported figures from SEC (XBRL) filings.
What is BioLife Solutions Inc.'s EV / EBITDA?
BioLife Solutions Inc.'s EV / EBITDA is 495.8×, based on as-reported figures from SEC (XBRL) filings.
What is BioLife Solutions Inc.'s Revenue (TTM)?
BioLife Solutions Inc.'s Revenue (TTM) is $106.7M, based on as-reported figures from SEC (XBRL) filings.
What is BioLife Solutions Inc.'s Net Income (TTM)?
BioLife Solutions Inc.'s Net Income (TTM) is $58.0M, based on as-reported figures from SEC (XBRL) filings.
What is BioLife Solutions Inc.'s EBITDA?
BioLife Solutions Inc.'s EBITDA is $3.4M, based on as-reported figures from SEC (XBRL) filings.
What is BioLife Solutions Inc.'s Diluted EPS (TTM)?
BioLife Solutions Inc.'s Diluted EPS (TTM) is 1.19, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue
YoY growth+21.5%+24.7%+24.3%+31.2%
Cost of revenue——
Gross profit——
% of revenue64.2%63.6%——
Operating expenses:
General and administrative
Sales and marketing
Research and development
IPR&D expense—
Intangible asset amortization
Total operating expenses
% of revenue58.3%63.5%-88.7%100.3%
Operating income (loss)
% of revenue6.0%0.1%7.2%-0.3%
Other income:
Interest income, net
Other income
Total other income, net
Income (loss) before income tax (benefit) expense
Income tax (benefit) expense
Net income (loss) from continuing operations
Net income (loss)
% of revenue158.4%4.3%58.9%2.2%
Net income (loss) per share (in dollars per share)
Net income per share (in dollars per share)